SPAC International's Chronic Care Management Physician, Patient and Pharmacy Portals Achieve ONC HIT 2014 Edition Modular EHR Certification from ICSA Labs

BAKERSFIELD, Calif., March 26, 2015 /PRNewswire/ -- Sargas Pharmaceutical Adherence and Compliance (SPAC) International's Chronic Care Management (CCM) Physician, Patient and Pharmacy Portals, Version 14.1 has achieved ONC HIT 2014 Edition Modular EHR certification, which designates that the software is capable of supporting eligible providers with meeting the Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA). SPAC CCM Physician, Patient and Pharmacy Portals were certified by ICSA Labs, an Office of the National Coordinator-Authorized Certification Body (ONC-ACB) and are compliant in accordance with applicable criteria adopted by the Secretary of Health and Human Services.

"With this certification, doctors are well prepared to demonstrate Meaningful Use and use our portals for providing chronic care management services," said Git Patel, CEO of SPAC International. "Our team of developers, staff and advisory board worked hard to achieve this certification to assist providers with a tool that helps them capture revenue while delivering better outcomes to cancer patients." CPT code 99490 is effective January 1st, 2015 for doctors to bill CCM services to Medicare patients with two or more chronic conditions. SPAC CCM Portals help automate this process along with their FDA approved mHealth applications.

"SPAC's technology is at the forefront of Federal Health IT Strategic Plan 2015-2020 such that it is interoperable among providers and can collect, share and use the health data to improve health, healthcare and reduce costs." Patel added.

ICSA Labs, an independent division of Verizon, offers vendor-neutral testing and certification. ONC HIT 2014 Edition Certification is granted to technologies that are capable of meeting the rigorous testing criteria developed to support providers who wish to demonstrate Stage 2 meaningful use, which focuses on the capability of health IT to deliver higher quality patient care and exchange clinical information securely.

SPAC CCM Physician, Patient and Pharmacy Portals Version 14.1 certification number is 150005R00. ONC HIT certification conferred by ICSA Labs does not represent an endorsement of the certified EHR technology by the U.S. Department of Health and Human Services.

SPAC CCM Physician, Patient and Pharmacy Portals Version 14.1 meet the following certification criteria:

  • §170.314(a)(1) C.P.O.E
  • §170.314(a)(3) Demographics
  • §170.314(a)(4) Vital Signs
  • §170.314(a)(5) Problem list
  • §170.314(a)(6) Medication list
  • §170.314(a)(7) Medication allergy list
  • §170.314(d)(1) Authentication, access, control, and authorizations
  • §170.314(d)(5) Automatic log-off
  • §170.314(d)(7) End-user device encryption
  • §170.314(e)(2) Clinical summary
  • §170.314(e)(3) Secure messaging
  • §170.314(g)(2) Automated measure calculation
  • §170.314(g)(3) Safety-enhanced design
  • §170.314(g)(4) Quality management system

There will be monthly fees to implement this EHR Module's capabilities in order to attempt to meet Meaningful Use objectives and provide chronic care management services. Connectivity fees are additional.

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.